CLQZX
Price
$12.74
Change
-$0.14 (-1.09%)
Updated
Nov 18 closing price
Net Assets
309.04M
GAFFX
Price
$86.02
Change
-$0.60 (-0.69%)
Updated
Nov 18 closing price
Net Assets
327.37B
Interact to see
Advertisement

CLQZX vs GAFFX

Header iconCLQZX vs GAFFX Comparison
Open Charts CLQZX vs GAFFXBanner chart's image
Columbia Disciplined Growth Inst
Price$12.74
Change-$0.14 (-1.09%)
VolumeN/A
Net Assets309.04M
American Funds Growth Fund of Amer F3
Price$86.02
Change-$0.60 (-0.69%)
VolumeN/A
Net Assets327.37B
CLQZX vs GAFFX Comparison Chart in %
View a ticker or compare two or three
VS
CLQZX vs. GAFFX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLQZX is a Hold and GAFFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 327B vs. CLQZX (309M). GAFFX pays higher dividends than CLQZX: GAFFX (0.56) vs CLQZX (0.00). CLQZX was incepted earlier than GAFFX: CLQZX (15 years) vs GAFFX (9 years). CLQZX (0.92) is less costly to investors than GAFFX (0.30). CLQZX is a more actively managed with annual turnover of: 68.00 vs. GAFFX (25.00). CLQZX has a lower initial minimum investment than GAFFX: CLQZX (2000) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 7.56 vs. CLQZX (6.26). GAFFX return over 5 years is better than : 34.72 vs. CLQZX (13.36).
CLQZXGAFFXCLQZX / GAFFX
Total Expense Ratio0.810.30270%
Annual Report Gross Expense Ratio0.920.30307%
Fund Existence15 years9 years-
Gain YTD14.36315.51093%
Front LoadN/AN/A-
Min. Initial Investment200010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets309M327B0%
Annual Yield % from dividends0.000.56-
Returns for 1 year6.267.5683%
Returns for 3 years51.6763.1782%
Returns for 5 years13.3634.7238%
Returns for 10 years34.57N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIPIX61.75N/A
N/A
ProFunds Biotechnology UltraSector Inv
MSOPX31.65N/A
N/A
Morgan Stanley Inst Global Opp C
FOCPX24.23N/A
N/A
Fidelity OTC
HWMIX55.54N/A
N/A
Hotchkis & Wiley Mid-Cap Value I
KLGAX54.99-0.65
-1.17%
NYLI WMC Growth Class A